US Stock MarketDetailed Quotes
CORBF Global Cord Blood
- 1.500
- 0.0000.00%
15min DelayClose Aug 28 16:00 ET
200.87MMarket Cap2.58P/E (TTM)
0.000High0.000Low1Volume1.000Open1.500Pre Close0.00Turnover0.00%Turnover Ratio2.58P/E (Static)133.91MShares2.33052wk High0.30P/B53.45MFloat Cap0.02152wk Low--Dividend TTM35.63MShs Float14.802Historical High--Div YieldTTM0.00%Amplitude0.021Historical Low0.000Avg Price1Lot Size
Global Cord Blood Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||
| Cash flow from continuing operating activities | -2.71%613.61M | 1.07%630.71M | -21.22%624M | 792.12M | |
| Net income from continuing operations | -1.30%509.48M | ---- | 8.05%516.21M | 61.83%477.73M | --295.2M |
| Operating gains losses | -16.79%2.01M | ---- | 1.09%2.41M | 429.05%2.39M | --451K |
| Depreciation and amortization | -2.38%47.92M | ---- | -0.73%49.09M | -5.57%49.45M | --52.37M |
| Deferred tax | 145.23%3.24M | ---- | 0.75%-7.15M | 50.94%-7.21M | ---14.69M |
| Change In working capital | -106.46%-3.77M | ---- | -8.98%58.33M | -82.37%64.08M | --363.45M |
| -Change in receivables | 14.53%-102.93M | ---- | -38.60%-120.44M | -186.16%-86.9M | ---30.37M |
| -Change in inventory | 21.90%-5.34M | ---- | 71.59%-6.84M | -351.43%-24.06M | ---5.33M |
| -Change in prepaid assets | 893.82%29.55M | ---- | 81.33%-3.72M | -549.14%-19.94M | ---3.07M |
| -Change in payables and accrued expense | -376.84%-35.9M | ---- | -54.66%12.97M | -6.12%28.6M | --30.46M |
| -Change in other current assets | --0 | ---- | ---3.04M | --0 | --0 |
| -Change in other current liabilities | -28.13%21.31M | ---- | -33.07%29.65M | 6.17%44.29M | --41.72M |
| -Change in other working capital | -40.20%89.55M | ---- | 22.66%149.75M | -63.01%122.09M | --330.04M |
| Cash from discontinued investing activities | |||||
| Operating cash flow | -2.71%613.61M | --162.03M | 1.07%630.71M | -21.22%624M | --792.12M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 2.35%-19.64M | 86.23%-20.11M | -383.49%-146.06M | -30.21M | |
| Net PPE purchase and sale | 2.35%-19.64M | ---- | -25.19%-20.11M | 46.84%-16.06M | ---30.21M |
| Net investment purchase and sale | --0 | ---- | --0 | ---130M | --0 |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 2.35%-19.64M | ---6.26M | 86.23%-20.11M | -383.49%-146.06M | ---30.21M |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | -27.25%-7.73M | -50.38%-6.07M | 80.94%-4.04M | -21.19M | |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---18.17M |
| Net other financing activities | -27.25%-7.73M | ---- | -50.38%-6.07M | -33.79%-4.04M | ---3.02M |
| Cash from discontinued financing activities | |||||
| Financing cash flow | -27.25%-7.73M | --0 | -50.38%-6.07M | 80.94%-4.04M | ---21.19M |
| Net cash flow | |||||
| Beginning cash position | 11.01%6.08B | ---- | 9.51%5.47B | 17.58%5B | --4.25B |
| Current changes in cash | -3.02%586.24M | ---- | 27.56%604.53M | -36.02%473.9M | --740.72M |
| Effect of exchange rate changes | 49.71%-1.06M | ---- | -230.85%-2.1M | -75.39%1.61M | --6.54M |
| End cash Position | 9.63%6.66B | ---- | 11.01%6.08B | 9.51%5.47B | --5B |
| Free cash flow | -2.62%593.82M | --162.03M | 1.68%609.82M | -21.23%599.76M | --761.43M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg